Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07796022 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical, Economic,and Psychosocial Burden of Thalassemia in Sohag

Study acronym: HBT-sohag
StatusNot Yet Recruiting
PhaseNot specified
Started2026-08
View on ClinicalTrials.gov ↗
This study aims to assess the clinical, economic, and psychosocial burden of thalassemia among affected children in Sohag. Clinically, the study will evaluate disease severity, transfusion requirements, iron overload, complications, and treatment-related factors. Economically, it will estimate direct medical costs, including transfusions, medications, investigations, hospital visits, and other healthcare expenses, as well as indirect costs such as school/work absenteeism and caregiver burden. Psychosocial aspects will include assessment of quality of life, psychological well-being, social functioning, and the impact of the disease on patients and their families.
Trial Details
NCT Number NCT07796022
Lead Sponsor Randa Elham Hamam
Conditions Thalassemia Particularly Transfusion Dependent Thalassemia
Enrollment 100 participants
Start Date 2026-08
Primary Completion 2027-06 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2026-08-31